Search Results
Results found for "Jana Selent"
- From Pipettes to Platforms: The Evolution of GPCR Research
a starting point for more ambitious questions about GPCR networks, biased signaling, and functional selectivity
- Molecular creativity in drug discovery
And that matter shapes everything: selectivity, safety, efficacy, and innovation.
- 📰 GPCR Weekly News
targets Constitutive activity of the dopamine receptor D5R, highly expressed in CA1 hippocampal neurons, selectively
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Cannabinoid 1 (CB1 ) receptor arrestin subtype-selectivity and phosphorylation dependence. GPCR Binders, Drugs, and more Ligands selectively tune the local and global motions of neurotensin receptor
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Yamina’s Corner reveals how fragmented data, undefined workflows, and ambiguous decision gates silently
- Why “Displacement” Misleads You: Allosteric Binding Demystified
If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
Individual cancer types were enriched for highly impactful, recurrent mutations at selected cognate positions
- 📰 GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- 📰 GPCR Weekly News, October 2 to 8, 2023
determined by NMR via Methyl Relaxation Structural determinants of sphingosine-1-phosphate receptor selectivity
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
from β-arrestin interaction and demonstrates altered regulatory outcomes downstream of this functional selectivity
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
The impact of ACEA is inhibited by the selective CB1 receptor antagonist, rimonabant.
- 📰 GPCR Weekly News, July 10 to 16, 2023
The potent BECN2-ATG14 coiled-coil interaction is selectively critical for endolysosomal degradation
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
From t-test, ANOVA, F-test selection to power analysis that prevents underpowered studies, this module
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
Synthetic signaling platforms permitting precise and selective Ca2+ signal transduction can improve dissection
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
. 📝 Manuscript summary deadline: 23 Sept 2025 📄 Submission deadline: 11 Jan 2026 Submit to Volume II Join the conversation on computational targeting and next-gen selectivity.
- 📰 GPCR Weekly News, May 15 to 21, 2023
GPCRs in Neuroscience Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic
- 📰 GPCR Weekly News, August 7 to 13, 2023
Submit your abstracts for poster presentation using this form - short talks will be selected from these
- 📰 GPCR Weekly News - January 2 to 8, 2023
Industry News Arcoscreen selected by START Lausanne to pitch at the START Global summit on the 23-24th
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
A ligand-based peptide probe could, offer the consistency and surface selectivity GPCR imaging demands
- Interacting binding insights and conformational consequences of the differential activity of...
In contrast, when the GPR55 receptor is simulated in complex with the selective agonist ML186, agonist-like
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
, you’ll learn how dialing receptor expression/coupling up or down reveals hidden partial agonism, “silent
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
In July 2025, Superluminal Medicines announced advancing a selective, biased, MC4R agonist small molecule
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Traditionally, it was believed that GPCRs selectively activate only their cognate G protein subtypes,
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
dimerization of GLP-1R results in decreased high-affinity binding to its natural ligand, GLP-1, while selectively
- 📰 GPCR Weekly News, March 4 to 10, 2024
analysis restricted to variants impacting gene function Interaction modes of human orexin 2 receptor with selective
- 📰 GPCR Weekly News, January 23 to 29, 2023
Methods & Updates in GPCR Research Development and Characterization of a Highly Selective Turn-On Fluorescent
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Screening technologies, structure-informed design, and AI are accelerating target selection.
- Decoding β-Arrestins: from Structure to function
While some receptors selectively activate specific G protein families, others are more versatile, yielding resonance energy transfer (BRET), and multi-color fluorescence microscopy assays employ conformation-selective
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
fluorescence chemistry, Celtarys custom-developed ligands offer both high affinity and exceptional selectivity
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Chem Rev. 2017 Jan 11;117(1):139-155. Greater specificity : allows for selective tracking of receptor subtypes in complex brain tissues. Chem Rev. 2017 Jan 11;117(1):139-155. doi: 10.1021/acs.chemrev.6b00177 Alavi MS, Shamsizadeh A, Azhdari-Zarmehri













